Kwame Koom-Dadzie, MD
Department of Hospital Medicine, Division of Internal Medicine
Present Title & Affiliation
Primary Appointment
Assistant Professor, Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Assistant Professor, Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2002 | Kwame Nkrumah University of Science and Technology, Kumasi, GH, MD |
| 1998 | Kwame Nkrumah University of Science and Technology, Kumasi, GH, Human Biology, BS |
Postgraduate Training
| 2006-2008 | Clinical Residency, Internal Medicine, Banner Good Samaritan Medical Center, Phoenix, Arizona |
| 2005-2006 | Clinical Internship, Internal Medicine, Banner Good Samaritan Medical Center, Phoenix, Arizona |
Licenses & Certifications
| 2025 | BLS |
| 2025 | ACLS |
| 2024 | Health Care Quality & Management |
| 2022 | DEA |
| 2022 | Physician Advisor, CHCQM |
| 2018 | Focused Practice in Hospital Medicine |
| 2013 | Texas Medical License |
| 2008 | American Board of Internal Medicine |
| 2005 | Arizona Medical Board |
Experience & Service
Faculty Academic Appointments
Attending Internist/Hospitalist, Internal Medicine, Houston Methodist Woodlands, Woodlands, TX, 2017 - 2018
Attending Internist/Hospitalist, Internal Medicine, Conroe Regional Medical Center, Conroe, TX, 2017 - 2018
Attending Internist/Hospitalist, Internal Medicine, Kingwood Medical Center, Kingwood, TX, 2016 - 2017
Attending Internist/Hospitalist, Internal Medicine, Team Health, Houston, TX, 2016 - 2017
Attending Internist/Hospitalist, Internal Medicine, Hospital Docs, PA,, Houston, TX, 2016 - 2018
Attending Internist/Hospitalist, Internal Medicine, Memorial Hermann Texas Medical Center, Houston, TX, 2014 - 2016
Assistant Professor, Internal Medicine, UT Health, Health Science Center at Houston, Houston, TX, 2014 - 2016
Attending Internist/Hospitalist, Internal Medicine, Memorial Hermann Woodlands, Woodlands, TX, 2014 - 2016
Attending Internist/Hospitalist, Internal Medicine, Cogent HMG Northeast, Humble, TX, 2014 - 2014
Attending Internist/Hospitalist, Internal Medicine, Memorial Hermann Northeast, Humble, TX, 2014 - 2014
Attending Internist/Hospitalist, Internal Medicine, Mercy Gilbert Medical Center, Gilbert, AZ, 2013 - 2014
Attending Internist/Hospitalist, Internal Medicine, Chandler Regional Medical Center, Chandler, AZ, 2013 - 2014
Attending Internist/Hospitalist, Internal Medicine, Alliance Hospitalist, Chandler, AZ, 2013 - 2014
Attending Internist – Locums Tenens, Internal Medicine, Medicus Healthcare, Houston, TX, 2011 - 2012
Attending Internist/Hospitalist, Internal Medicine, Banner MD Anderson Cancer Center, Gilbert, AZ, 2009 - 2014
Attending Internist/Hospitalist, Internal Medicine, Banner Gateway Medical Center, Gilbert, AZ, 2008 - 2013
Extramural Institutional Committee Activities
Lead, Extended recovery and Observation prolonged stay Pilot Work Group, The University of Texas MD Anderson Cancer Center, 2024 - Present
Member, Dept. of Medicine New hire On board content Experts, The University of Texas MD Anderson Cancer Center, 2024 - Present
Member, Project Echo Ghana, The University of Texas MD Anderson Cancer Center, 2024 - Present
Member, Hospital Medicine Throughput improvement ,workgroup, The University of Texas MD Anderson Cancer Center, 2024 - Present
Member, Bimonthly Extended stay Operations Work Group, The University of Texas MD Anderson Cancer Center, 2023 - Present
Lead, Bimonthly Extended stay Operations Work Group, The University of Texas MD Anderson Cancer Center, 2020 - 2023
Member, Clinical Effectiveness Subcommittee, The University of Texas MD Anderson Cancer Center, 2019 - Present
Member, Utilization Review Subcommittee, The University of Texas MD Anderson Cancer Center, 2019 - Present
Member, Utilization Review Core Team, The University of Texas MD Anderson Cancer Center, 2019 - Present
Member, Weekly Utilization Review work flow for short stay, The University of Texas MD Anderson Cancer Center, 2019 - Present
Honors & Awards
| 2021 | Utilization Review Committee Outstanding leadership and service award |
| 2019 - 2024 | Designation of Hospital Medicine Fellowship |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2021. APP Education series: Disimpacting the Bowel. Houston, Texas, US.
- 2020. Problems associated with Extended Length of Stay. Conference. GIM Research Conference, US.
- 2020. 18-day Medicare attestation BPA Approval. Conference. ECMS & Medical Practice Committee meetings, US.
Regional Presentations
- 2019. Overview of Polyuria. Conference. Academic Hospital Conference, US.
Grant & Contract Support
| Date: | 2006 - 2007 |
| Title: | Yttrium-90 microspheres |
| Funding Source: | BANNER GOOD SAMARITAN HOSPITAL |
| Role: | PI |
Selected Publications
Peer-Reviewed Articles
- Simbaqueba Clavijo, CA, Odaro, OE, Gandhi, A, Koom-Dadzie, K, Musaelyan, A, Dickson, KB, Chua, R, Bhise, VR, Amoateng, MD, Tomy, S, Leal Alviarez, DJ, Phyu, EM, Bogdanich, I, Andersen, C, Sheshadri, A, Palaskas, NL, Halm, J, Manzano, JM. Immunotherapy-Related Adverse Events and Clinical Outcomes in Adult Solid-Tumor Patients Admitted to an Onco-Hospitalist Medicine Service. Cancers 17(3), 2025. e-Pub 2025. PMID: 39941771.
- Manzano, JM, Sahar, H, Aldrich, J, Lu, M, Shoukier, M, Peterson, CB, Dickson, KB, Koom-Dadzie, K, Kheder, E, Franco Vega, M, Mohammed, AD, Muthu, M, Simbaqueba Clavijo, CA, Senechalle, MS, Brito-Dellan, N. Treatment patterns and outcomes of high-grade immune checkpoint inhibitor-related pneumonitis in an oncology hospitalist service. Supportive Care in Cancer 32(3), 2024. e-Pub 2024. PMID: 38366007.
- Arthur, JA, Edwards, T, Lu, Z, Amoateng, MD, Koom-Dadzie, K, Zhu, H, Long, JP, Do, K, Bruera, E. Healthcare provider perceptions and reported practices regarding opioid prescription for patients with chronic cancer pain. Supportive Care in Cancer 32(2), 2024. e-Pub 2024. PMID: 38252311.
- Bann, M, Meo, N, Lopez, JP, Ou, A, Rosenthal, M, Khawaja, H, Goodman, LA, Barone, M, Coleman, B, High, HJ, Overbeek, L, Shelbourn, P, VerMaas, L, Baughman, A, Sekaran, A, Cyrus, R, O'Dorisio, N, Beatty, L, Loica-Mersa, S, Kubey, A, Jaffe, R, Vokoun, C, Koom-Dadzie, K, Graves, K, Tuck, M, Helgerson, P. Medically ready for discharge: A multisite “point‐in‐time” assessment of hospitalized patients. Journal of Hospital Medicine 18(9):795-802, 2023. e-Pub 2023. PMID: 37553979.
- Dickson K, Koom-Dadzie K, Brito-Dellan N, Escalante C. Risks, diagnosis, and management of recurrent cancer-associated thrombosis (CAT). Supportive Care in Cancer 30(10):8539-8545, 2022. e-Pub 2022. PMID: 35699781.
- Manzano JM, Muthu M, Kheder E, Mohammed A, Halm J, Dickson K, Ali N, Leung C, Koom-Dadzie K, Rubio D, Odaro O, Sibille M, Etchegaray M, Wilson K, Lin H, George M. Hospitalization characteristics and outcomes of patients with cancer and COVID-19 at a comprehensive cancer center. Supportive Care in Cancer 30(9):7783-7788, 2022. e-Pub 2022. PMID: 35705751.
Review Articles
- Gandhi A, Phyu EM, Koom-Dadzie K, Dickson KB, Halm J. GLP-1 Receptor Agonists at the Crossroads of Circadian Biology, Sleep, and Metabolic Disease. International journal of molecular sciences 27(6), 2026. e-Pub 2026. PMID: 41898712.
Abstracts
- Clavijo CS, Koom-Dadzie K, Dickson K, Musaelyan A, Amoateng D, Phyu EM, Bogdanich I, Bhise V, Leal-Alvarez D, Chua R, Gandhi A, Tomy S, Halm J, Manzano JG. 1192 Immunotherapy related adverse events and clinical outcomes in adult solid tumor cancer patients on immune checkpoint inhibitors admitted to a tertiary medical center hospitalist medicine service. JITC 12, 2024. e-Pub 2024.
- Ali, Kheder E, Dickson K, Rubio D, Koom-Dadzie K, Edelkamp P, Lin HY, Muthu M, Mohammed A, Leung C, Odaro O, Sibille M, George MC, Halm J, Manzano JM. Association of presenting symptoms with COVID-19 disease severity and outcomes among hospitalized patients with cancer and COVID-19. ASCO, 2023. e-Pub 2023.
- Manzano J, Muthu M, EKheder, Mohammed A, Lin H, Dickson K, Kheder E, Ali N, Leung C, Koom-Dadzie K, Rubio D, Odaro O, Sibille M, Halm J, George M. RISK FACTORS FOR SEVERE COVID-19 DISEASE AND MORTALITY AMONG PATIENTS WITH CANCER. Supportive Care in Cancer:31:399, 2023. e-Pub 2023.
- Manzano J, Wilson K, Muthu M, Khederkjuyt E, Mohammed A, Dickson K, Ali N, Leung C, Koom-Dadzie K, Rubio D, Odaro O, Sibille M, Etchegaray M, Halm J, George M. HOSPITALIZATION CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH CANCER AND COVID-19. MASCC/ISOO Annual Meeting, 2021. e-Pub 2021.
- Sahar N, Aldrich J, Peterson CB, Brito-Dellan N, Lu M, Shoukier M, Dickson K, Koom-Dadzie K, Kheder E, Franco-Vega M, Mohammed A, Muthu M, Simbaqueba C, Sibille M, Manzano JM. Immune checkpoint inhibitor (ICI)-related pneumonitis among patients with lung cancer admitted to an Oncology Hospitalist Service: Treatment patterns and hospitalization outcomes. Journal of Clinical Oncology, 2021. e-Pub 2021.
- Lu M, Roh J, Manzano JG, Franco-Vega M, Chua R, Koom-Dadzie K, Zhou Y, Tung W, Singhal R, Chung J, Okhuysen P, Lu HL, Ali O. Baseline prescription rate of Pneumocystis Jirovencii Pneumonia prophylaxis for cancer patients on glucocorticoids for Immune-Checkpoint Inhibitor induced toxicity at hospital discharge. 2024 IOTOX Symposium.
Patient Reviews
CV information above last modified July 22, 2026